Holen Sie sich die Stockscreener-App
244.96
0.36%
-0.89
Handel nachbörslich:
244.96
Schlusskurs vom Vortag:
$245.85
Offen:
$243.59
24-Stunden-Volumen:
542.03K
Relative Volume:
0.63
Marktkapitalisierung:
$15.90B
Einnahmen:
$4.44B
Nettoeinkommen (Verlust:
$29.49M
KGV:
-13,313.04
EPS:
-0.0184
Netto-Cashflow:
$1.19B
1W Leistung:
-4.52%
1M Leistung:
+2.90%
6M Leistung:
+47.29%
1J Leistung:
+109.96%
1-Tages-Spanne:
$240.63
$245.35
1-Wochen-Bereich:
$240.63
$261.27
52-Wochen-Spanne:
$116.53
$265.05
Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile
Firmenname
Jazz Pharmaceuticals Plc
Sektor
Branche
Telefon
353-1-634-7800
Adresse
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Compare JAZZ vs VRTX, REGN, ARGX, RVMD, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JAZZ
Jazz Pharmaceuticals Plc
|
244.96 | 16.16B | 4.44B | 29.49M | 1.19B | -0.0184 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-10 | Fortgesetzt | Raymond James | Outperform |
| 2026-02-27 | Eingeleitet | Barclays | Overweight |
| 2025-11-24 | Herabstufung | UBS | Buy → Neutral |
| 2025-07-15 | Eingeleitet | Deutsche Bank | Buy |
| 2025-03-07 | Hochstufung | UBS | Neutral → Buy |
| 2025-02-26 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-02-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-06-05 | Eingeleitet | Goldman | Buy |
| 2024-01-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-11-27 | Herabstufung | UBS | Buy → Neutral |
| 2023-09-29 | Eingeleitet | Raymond James | Mkt Perform |
| 2023-06-12 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2022-12-09 | Hochstufung | Goldman | Neutral → Buy |
| 2022-06-14 | Eingeleitet | UBS | Buy |
| 2022-04-06 | Herabstufung | Goldman | Buy → Neutral |
| 2021-11-19 | Fortgesetzt | Goldman | Buy |
| 2021-10-07 | Fortgesetzt | Jefferies | Buy |
| 2021-10-05 | Eingeleitet | Citigroup | Buy |
| 2021-09-23 | Eingeleitet | Needham | Buy |
| 2021-05-19 | Fortgesetzt | JP Morgan | Overweight |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2021-02-05 | Bestätigt | H.C. Wainwright | Buy |
| 2021-02-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-01-29 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-16 | Eingeleitet | UBS | Buy |
| 2020-11-03 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-09 | Bestätigt | H.C. Wainwright | Buy |
| 2020-09-14 | Herabstufung | Goldman | Neutral → Sell |
| 2020-09-14 | Fortgesetzt | JP Morgan | Overweight |
| 2020-08-06 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-28 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-07-23 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-04-06 | Eingeleitet | Jefferies | Buy |
| 2020-03-12 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2020-01-08 | Eingeleitet | Goldman | Neutral |
| 2019-08-21 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2019-06-11 | Eingeleitet | Barclays | Overweight |
| 2019-03-20 | Eingeleitet | SunTrust | Buy |
| 2018-12-14 | Eingeleitet | Wolfe Research | Peer Perform |
| 2018-11-08 | Bestätigt | B. Riley FBR | Buy |
| 2018-08-08 | Bestätigt | Stifel | Buy |
| 2018-07-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-03-23 | Bestätigt | H.C. Wainwright | Neutral |
| 2018-03-19 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
Alle ansehen
Jazz Pharmaceuticals Plc Aktie (JAZZ) Neueste Nachrichten
Jazz Pharmaceuticals PLC at TD Cowen Oncology Innovation Summit (Virtual) Transcript - GuruFocus
Understanding HER2 Expression in Gastroesophageal AdenocarcinomaJazz Pharmaceuticals - Oncodaily
Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Assenagon Asset Management S.A. - marketbeat.com
Irish Jazz Pharmaceuticals acquires American Actio for $1.32 billion - AKM.RU
Jazz Pharmaceuticals (JAZZ) Stock Looks Cheap On Earnings While Broader Checks Stay Mixed - simplywall.st
Jazz Pharmaceuticals Bolsters Epilepsy Division With Actio Biosciences Buyout (JAZZ) - Seeking Alpha
Wedge Capital Management L L P NC Sells 33,467 Shares of Jazz Pharmaceuticals PLC $JAZZ - marketbeat.com
5 Revealing Analyst Questions From Jazz Pharmaceuticals’s Q2 Earnings Call - Yahoo Finance
JAZZ Maintained by Morgan Stanley -- Price Target Raised to $283 - GuruFocus
Jazz Pharmaceuticals (JAZZ) Acquires Actio Biosciences for $820 Million - GuruFocus
Jazz Pharmaceuticals' Actio Acquisition 'Makes Sense,' Has Good Synergy, RBC Says - marketscreener.com
Morgan Stanley Adjusts Jazz Pharmaceuticals PT to $283 From $280, Maintains Overweight Rating - marketscreener.com
Jazz Pharmaceuticals buys Actio for up to $1.3bn - BioXconomy
Jazz Pharmaceuticals to acquire Actio Biosciences for $820m upfront - Pharmaceutical Technology
Jazz Pharmaceuticals (JAZZ) Short Interest & Short Float | Updated Aug 2026 $JAZZ - marketbeat.com
Jazz Pharmaceuticals (JAZZ) Q2 2026 Earnings Call Transcript - The Globe and Mail
Jazz Pharmaceuticals plc (JAZZ) stock price, news, quote and history - Yahoo Finance Singapore
Jazz Pharmaceuticals to Acquire Actio Biosciences in Merger - TipRanks
Jazz Pharmaceuticals (JAZZ) plans $820M Actio Biosciences deal plus $500M milestones - Stock Titan
Jazz Pharmaceuticals to acquire Actio Biosciences for $820M - Investing.com India
Jazz Pharmaceuticals' (NASDAQ:JAZZ) Solid Earnings Are Supported By Other Strong Factors - 富途牛牛
Jazz Pharma Buying Actio In Up To $1.32B Epilepsy Push - Law360
Jazz to buy rare epilepsy drugmaker in potentially $1.3B deal - BioPharma Dive
Jazz bets on epilepsy treatment with up to $1.32 billion deal for Actio - Reuters
Jazz commits up to $1.3B to buy Actio, bolster epilepsy pipeline - BioSpace
JAZZ Looks 70.7% Overvalued on GF Value™ Amid $820M Actio Biosci - GuruFocus
Unlocking Jazz (JAZZ) International Revenues: Trends, Surprises, and Prospects - Yahoo Finance
Jazz Pharmaceuticals to Acquire Actio Biosciences in Deal Worth Up to $1.32 Billion - citybiz
JAZZ Looks 68.7% Overvalued on GF Value™ After Actio Biosciences Acquisition - GuruFocus
Jazz Pharmaceuticals to Acquire Rare Epilepsy Specialist Actio - TipRanks
Jazz Pharmaceuticals to acquire Actio Biosciences for $820M By Investing.com - Investing.com Australia
Jazz Pharmaceuticals to acquire Actio Biosciences for $820M upfront, gaining a new epilepsy drug ABS-1230. - Pluang
Jazz Pharmaceuticals to Acquire Actio Biosciences, Expanding Rare Epilepsy Portfolio - PR Newswire
Royal Bank of Canada Has $8.56 Million Stake in Jazz Pharmaceuticals PLC $JAZZ - marketbeat.com
Jazz Pharmaceuticals (JAZZ): Investor Outlook on a Biotech Powerhouse with a 9.51% Upside Potential - DirectorsTalk Interviews
Jazz Pharmaceuticals PLC (JAZZ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Jazz Pharmaceuticals plc 2026 Q2ResultsEarnings Call Presentation (NASDAQ:JAZZ) 2026-08-07 - Seeking Alpha
Jazz Pharmaceuticals plc SEC Filing (Aug 7, 2026) - Stock Titan
Jazz Pharmaceuticals plc (JAZZ) News, Articles, Events & Latest Updates - Stocktwits
JAZZ vs. TECH: Which Stock Is the Better Value Option? - Yahoo Finance
FMR LLC and Abigail Johnson disclose 7.4% Jazz Pharmaceuticals (JAZZ) ownership - Stock Titan
Jazz Pharmaceuticals (JAZZ) Director Bruce Cozadd Sells 6,000 Sh - GuruFocus
Jazz Pharmaceuticals Plc Just Missed EPS By 13%: Here's What Analysts Think Will Happen Next - Moomoo
What Does Jazz Pharmaceuticals (JAZZ) Raised Guidance Mean With FDA Decisions Ahead? - Yahoo Finance
Jazz Pharmaceuticals (JAZZ) Stock May Stay Below Fair Value Following Raised Guidance - simplywall.st
Jazz Pharmaceuticals' Re-Rating Story Has Legs (NASDAQ:JAZZ) - Seeking Alpha
Jazz Pharmaceuticals PLC $JAZZ Stake Boosted by Bank of America Corp DE - marketbeat.com
Amundi Acquires 53,454 Shares of Jazz Pharmaceuticals PLC $JAZZ - marketbeat.com
Insider Selling: Jazz Pharmaceuticals (NASDAQ:JAZZ) Director Sells $1,517,880.00 in Stock - marketbeat.com
Jazz Pharmaceuticals stock hits all-time high at 261.46 USD - Investing.com
JAZZ PHARMACEUTICALS PLC : PIPER SANDLER RAISES TARGET PRICE TO $310 FROM $301 - webull.com
Finanzdaten der Jazz Pharmaceuticals Plc-Aktie (JAZZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):